Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis.
Invasion by gram-positive and gram-negative bacterial organisms is characterized immunopathologically by the activation of mononuclear phagocytic cells, leading to the elaboration of macrophage-derived regulatory and chemotactic factors, and the resultant influx of inflammatory leukocytes. Little is known regarding the mechanisms by which gram-positive organisms initiate macrophage activation and subsequent inflammation. In this investigation, we postulated that lipoteichoic acid (LTA) purified from two different gram-positive bacterial species was an important signal for the expression of chemotactic cytokines from human peripheral blood monocytes (PBM). In initial experiments, we demonstrated that cell-associated interleukin-8 (IL-8) was expressed by mononuclear phagocytes present in inflamed areas of endocardium in cases of acute Staphylococcus aureus endocarditis. We next demonstrated that LTA purified from either Staphylococcus aureus or Streptococcus pyogenes induced the time- and dose-dependent expression of IL-8 mRNA and protein from human PBM. The expression of IL-8 mRNA from LTA- but not lipopolysaccharide (LPS)-treated PBM was superinduced by concomitant treatment with cycloheximide, indicating that the expression of IL-8 mRNA from LTA-treated PBM was negatively controlled by repressor proteins. Furthermore, mRNA stability studies indicated that IL-8 mRNA was less stable in the presence of LTA than in the presence of LPS. Our findings indicate that LTA can induce the secretion of the polymorphonuclear leukocyte chemotactic factor IL-8 and that LTA may be an important cellular mediator of inflammatory cell recruitment that characterizes immune responses to gram-positive bacterial infections.
Standiford
T J
TJ
Department of Medicine, University of Michigan Medical School, Ann Arbor 48109-0360.
Arenberg
D A
DA
Danforth
J M
JM
Kunkel
S L
SL
VanOtteren
G M
GM
Strieter
R M
RM
D003513:Cycloheximide / Q000494:pharmacology; D004697:Endocarditis, Bacterial / Q000503:physiopathology; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D016209:Interleukin-8 / Q000235:genetics / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000494:pharmacology*; D009000:Monocytes / Q000187:drug effects* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D013203:Staphylococcal Infections / Q000503:physiopathology; D013211:Staphylococcus aureus / Q000737:chemistry; D013297:Streptococcus pyogenes / Q000737:chemistry; D013682:Teichoic Acids / Q000494:pharmacology*
D016209:Interleukin-8; D008070:Lipopolysaccharides; D012333:RNA, Messenger; D013682:Teichoic Acids; C009900:lipoteichoic acid; D003513:Cycloheximide